Literature DB >> 20084362

The rise and fall of the metabolic syndrome.

K Borch-Johnsen, N Wareham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20084362     DOI： 10.1007/s00125-010-1659-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  12 in total

Review 1.  Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence.

Authors:  Earl S Ford
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

2.  Role of the metabolic syndrome in risk assessment for coronary heart disease.

Authors:  Priya Kohli; Philip Greenland
Journal:  JAMA       Date:  2006-02-15       Impact factor: 56.272

Review 3.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

4.  Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

Authors:  Michael P Stern; Ken Williams; Clicerio González-Villalpando; Kelly J Hunt; Steven M Haffner
Journal:  Diabetes Care       Date:  2004-11       Impact factor: 19.112

Review 5.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

6.  The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation.

Authors:  R K Simmons; K G M M Alberti; E A M Gale; S Colagiuri; J Tuomilehto; Q Qiao; A Ramachandran; N Tajima; I Brajkovich Mirchov; A Ben-Nakhi; G Reaven; B Hama Sambo; S Mendis; G Roglic
Journal:  Diabetologia       Date:  2009-12-11       Impact factor: 10.122

7.  Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome.

Authors:  Darcy B Carr; Kristina M Utzschneider; Rebecca L Hull; Keiichi Kodama; Barbara M Retzlaff; John D Brunzell; Jane B Shofer; Brian E Fish; Robert H Knopp; Steven E Kahn
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

8.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

9.  Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.

Authors:  Naveed Sattar; Alex McConnachie; A Gerald Shaper; Gerard J Blauw; Brendan M Buckley; Anton J de Craen; Ian Ford; Nita G Forouhi; Dilys J Freeman; J Wouter Jukema; Lucy Lennon; Peter W Macfarlane; Michael B Murphy; Chris J Packard; David J Stott; Rudi G Westendorp; Peter H Whincup; James Shepherd; S Goya Wannamethee
Journal:  Lancet       Date:  2008-05-22       Impact factor: 79.321

Review 10.  Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials.

Authors:  Rodrigo M Lago; Premranjan P Singh; Richard W Nesto
Journal:  Lancet       Date:  2007-09-29       Impact factor: 79.321
View more
  17 in total

1.  Parental and offspring associations of the metabolic syndrome in the Fels Longitudinal Study.

Authors:  Roy T Sabo; Zheng Lu; Xiaoyan Deng; Chunfeng Ren; Stephen Daniels; Silva Arslanian; Shumei S Sun
Journal:  Am J Clin Nutr       Date:  2012-07-18       Impact factor: 7.045

Review 2.  Metabolic syndrome, aging and involvement of oxidative stress.

Authors:  Francesca Bonomini; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

Review 3.  The new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies.

Authors:  Michael Pfeiffer; Rüdiger von Bauer; Peter P Nawroth
Journal:  Langenbecks Arch Surg       Date:  2011-03-30       Impact factor: 3.445

4.  Metabolic syndrome components are associated with future medical costs independent of cardiovascular hospitalization and incident diabetes.

Authors:  Gregory A Nichols; Edward J Moler
Journal:  Metab Syndr Relat Disord       Date:  2010-12-18       Impact factor: 1.894

5.  Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk.

Authors:  Jennifer L Kuk; Chris I Ardern
Journal:  Diabetes Care       Date:  2010-08-10       Impact factor: 17.152

Review 6.  Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?

Authors:  Gábor Firneisz
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

7.  Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study.

Authors:  F J Martinez-Martin; H Rodriguez-Rosas; I Peiro-Martinez; P Soriano-Perera; P Pedrianes-Martin; C Comi-Diaz
Journal:  J Hum Hypertens       Date:  2010-11-25       Impact factor: 3.012

8.  Comparison of accuracy of diabetes risk score and components of the metabolic syndrome in assessing risk of incident type 2 diabetes in Inter99 cohort.

Authors:  Tracy B Shafizadeh; Edward J Moler; Janice A Kolberg; Uyen Thao Nguyen; Torben Hansen; Torben Jorgensen; Oluf Pedersen; Knut Borch-Johnsen
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

9.  Metabolic syndrome in estonia: prevalence and associations with insulin resistance.

Authors:  Triin Eglit; Tarvo Rajasalu; Margus Lember
Journal:  Int J Endocrinol       Date:  2012-02-25       Impact factor: 3.257

10.  Adiponectin in eutrophic and obese children as a biomarker to predict metabolic syndrome and each of its components.

Authors:  Miguel Klünder-Klünder; Samuel Flores-Huerta; Rebeca García-Macedo; Jesús Peralta-Romero; Miguel Cruz
Journal:  BMC Public Health       Date:  2013-01-30       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.